United Therapeutics Stock
United Therapeutics Stock
With 32 Buy predictions and 1 Sell predictions United Therapeutics is one of the favorites of our community.
With a target price of 507 € there is a slightly positive potential of 4.15% for United Therapeutics compared to the current price of 486.8 €.
So far the community has only identified positive things for United Therapeutics stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of United Therapeutics in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of United Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| United Therapeutics | -0.100% | -0.429% | 3.615% | 96.730% | 14.042% | 134.957% | 184.971% |
| Ionis Pharmaceuticals Inc. | 1.750% | -1.110% | -0.804% | 169.073% | -5.650% | 87.980% | 80.264% |
| Ligand Pharmaceuticals | 1.140% | -2.235% | -4.372% | 90.217% | 5.422% | 153.623% | 34.564% |
| Novocure Ltd | -0.460% | -1.181% | -17.043% | -37.089% | -20.300% | -84.943% | -91.850% |
Comments
United Therapeutics (UTHR) is now covered by Raymond James Financial, Inc.. They set an "outperform" rating and a $700.00 price target on the stock.
Show more
Ratings data for UTHR provided by MarketBeat
United Therapeutics (UTHR) had its price target raised by HC Wainwright from $600.00 to $660.00. They now have a "buy" rating on the stock.
Show more
Ratings data for UTHR provided by MarketBeat
United Therapeutics (UTHR) had its price target raised by TD Cowen from $575.00 to $660.00. They now have a "buy" rating on the stock.
Show more
Ratings data for UTHR provided by MarketBeat